Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53
Authors
Keywords
HDAC inhibitor, Valproic acid, Radiotherapy, Colorectal cancer, Capecitabine, p53
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 36, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-06
DOI
10.1186/s13046-017-0647-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The mitochondrial voltage-dependent anion channel 1 in tumor cells
- (2015) Varda Shoshan-Barmatz et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways
- (2015) M. A. Morgan et al. CLINICAL CANCER RESEARCH
- Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway
- (2015) Alessandra Leone et al. FREE RADICAL BIOLOGY AND MEDICINE
- A perspective on the current treatment strategies for locally advanced rectal cancer
- (2015) Antonio Avallone et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma
- (2015) Andra V. Krauze et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Neoadjuvant treatment for locally advanced rectal cancer: a systematic review
- (2015) Keisuke Uehara et al. SURGERY TODAY
- Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid - short RadioTherapy - rectum 3rd trial)
- (2014) Antonio Avallone et al. BMC CANCER
- Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers
- (2014) Jennifer J. Wheler et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Could valproic acid be an effective anticancer agent? The evidence so far
- (2014) Seth A Brodie et al. Expert Review of Anticancer Therapy
- p53 Activates Either Survival or Apoptotic Signaling in Lupulone-Treated Colon Adenocarcinoma Cells and Derived Metastatic C
- (2014) Virginie Lamy et al. Translational Oncology
- Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair
- (2013) B Groselj et al. BRITISH JOURNAL OF CANCER
- p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors
- (2013) J Sonnemann et al. BRITISH JOURNAL OF CANCER
- The novel HDAC inhibitor NDACI054 sensitizes human cancer cells to radiotherapy
- (2013) Stephanie Hehlgans et al. RADIOTHERAPY AND ONCOLOGY
- The effect of chemotherapy or radiotherapy on thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in cancer of the uterine cervix
- (2012) Kiyoshi Hasegawa et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: The molecular choreography
- (2012) Larry H. Thompson MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
- (2012) W Yan et al. ONCOGENE
- Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma
- (2012) Marie Saelen et al. Radiation Oncology
- Histone Deacetylase Inhibitors Sensitize Human Non-small Cell Lung Cancer Cells to Ionizing Radiation Through Acetyl p53-Mediated c-myc Down-Regulation
- (2011) Sung-Keum Seo et al. Journal of Thoracic Oncology
- Widdrol activates DNA damage checkpoint through the signaling Chk2–p53–Cdc25A–p21–MCM4 pathway in HT29 cells
- (2011) Hee Jung Yun et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cells
- (2011) Laura Bianchi et al. PROTEOMICS
- Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo
- (2010) Varda Shoshan-Barmatz et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase
- (2010) E Di Gennaro et al. BRITISH JOURNAL OF CANCER
- Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or Raltitrexed
- (2010) Elena Di Gennaro et al. CANCER BIOLOGY & THERAPY
- Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21waf1/cip1 expression
- (2010) Rintaro Noro et al. CANCER SCIENCE
- Mre11–Rad50–Nbs1 conformations and the control of sensing, signaling, and effector responses at DNA double-strand breaks
- (2010) Gareth J. Williams et al. DNA REPAIR
- Molecular and Therapeutic Potential and Toxicity of Valproic Acid
- (2010) Sébastien Chateauvieux et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- HDAC Inhibitor-Mediated Radiosensitization in Human Carcinoma Cells: A General Phenomenon?
- (2010) In Ah KIM et al. JOURNAL OF RADIATION RESEARCH
- Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study
- (2010) Anne Hansen Ree et al. LANCET ONCOLOGY
- Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining
- (2010) Kyle M Miller et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- HDAC Inhibitor, Valproic Acid, Induces p53-Dependent Radiosensitization of Colon Cancer Cells
- (2009) Xufeng Chen et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Clinical and Biological Effects of Valproic Acid as a Histone Deacetylase Inhibitor on Tumor and Surrogate Tissues: Phase I/II Trial of Valproic acid and Epirubicin/FEC
- (2009) P. Munster et al. CLINICAL CANCER RESEARCH
- Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells
- (2009) William Fazzone et al. INTERNATIONAL JOURNAL OF CANCER
- Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis
- (2009) F. Bruzzese et al. MOLECULAR CANCER THERAPEUTICS
- Valproic acid as a therapeutic agent for head and neck squamous cell carcinomas
- (2008) Rafael B. Erlich et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Postradiation Sensitization of the Histone Deacetylase Inhibitor Valproic Acid
- (2008) P. Chinnaiyan et al. CLINICAL CANCER RESEARCH
- Transcriptional control of human p53-regulated genes
- (2008) Todd Riley et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started